July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
P2X7 antagonist attenuates retinal inflammation and neovascularization induced by oxidized low density lipoprotein in mice
Author Affiliations & Notes
  • Mingzhu Yang
    Henan Eye Hospital, Henan Provincial People's Hospital, Zhengzhou, China
  • Footnotes
    Commercial Relationships   Mingzhu Yang, None
  • Footnotes
    Support  National Natural Science Foundation of China grants(81271033,81470621)
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 368. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Mingzhu Yang; P2X7 antagonist attenuates retinal inflammation and neovascularization induced by oxidized low density lipoprotein in mice. Invest. Ophthalmol. Vis. Sci. 2019;60(9):368.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To investigate whether A740003, a P2X7 receptor antagonist, could prevent retinal inflammation and neovascularization induced by oxidized low density lipoprotein (ox-LDL) and to explore the underlying mechanisms in human RPE cells and in mice.

Methods : ARPE-19 cells were incubated with A740003 for 2 hours before ox-LDL treatment. Same concentrations of DMSO were used as vehicle controls. C57BL/6 mice were subretinally injected with ox-LDL to induce retinal inflammation and neovascularization and PBS was used as control. A740003 (30 mg/kg/d) or vehicle was administrated intraperitoneally starting from day 3 before to day 14 after ox-LDL injection (n=6). Retinal neovascularization was detected by whole flat mount of retinas stained with isolectin-B4, CD31 and VEGF antibodies. Retinal function was assessed by dark- and light-adapted ERG. The mRNA and protein levels of NLRP3, Caspase-1, pIKBα, IKBα, HIF-1α and VEGF in retinas of mice and ARPE-19 cells were detected by qPCR and Western bloting. IL-1β, IL-18 and TNF-α were determined by ELISA assay.

Results : Compared to vehicle group, A740003 decreased the expression of NLRP3, Caspase-1, HIF-1α and VEGF in ARPE-19 cells at RNA and protein levels. Inflammatory cytokines including IL-1β, IL-18, TNF-α and phosphorylation of IKBα was also down-regulated by A740003. Whole flat mount of retinas showed that A740003 inhibited the angiogenesis in retinas induced by ox-LDL. Compared with vehicle treated mice, the mRNA and protein levels of NLRP3 Caspase-1, HIF-1α and VEGF decreased and the phosphorylation of IKBα was inhibited in the retinas of A740003 treated mice. The b- and a-wave amplitudes of ERG were alleviated in the A740003 treated mice compared with vehicle group.

Conclusions : A740003 significantly reduced ocular inflammatory responses and VEGF level in ARPE-19 cells. In addition, the P2X7 antagonist inhibited retinal inflammation and neovascularization, and protected retinal function in ox-LDL induced impairment in mice. The protective effects of A740003 were associated with regulating of NLRP3 inflammasome and NF-κB pathway, as well as inhibition of HIF-1α and VEGF.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×